National Cancer Institute / Midwives American College of Obstetricians / ME Indianapolis Mennonite College of Nursing / University of Chicago DES Cancer Network RESOLVE / Women’s Health National Cancer Institute / /
MedicalCondition
miscarriages / infertility / Hormonal Transpacental Carcinogenesis / premature births / diseases / noncancerous epididymal cysts / breast cancer / injuries / rare vaginal cancer / adenocarcinoma / /
Organization
National Cancer Institute / American Academy / Congress / Illinois State University / Health National Women’s Health Network Office on Women / Food and Drug Administration / National DES Task Force / Reproductive Health Professionals National Association of Nurse Practitioners / Department of Health and Human Services DES Action USA Registry for Research / Physician Assistants American College / National Infertility Association DES Sons Network Y-ME Indianapolis Mennonite College of Nursing / American Nurses Association Association / Nurse-Midwives American College of Obstetricians / Centers for Disease Control and Prevention / University of Chicago DES Cancer Network RESOLVE / / /
Position
physician advisory recommending / /
Product
Diethylstilbestrol / /
PublishedMedium
the New England Journal of Medicine / the American Journal / /
CDC’s DES Update Backgrounder About Diethylstilbestrol (DES) History Diethylstilbestrol (DES) is a synthetic estrogen that physicians prescribed to pregnant women during 1938–1971 to prevent miscarriages or premature